RNS Number : 7728R

Societe Generale SA

10 March 2021

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.       KEY INFORMATION

Name of person dealing (Note 1)	Société Générale S.A.
Company dealt in	Willis Towers Watson plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	US$0.000304635 ordinary shares
Date of dealing	09/03/2021

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	399,709	0.31	8,760	0.01
(2) Derivatives (other than options)	1,435	0.00	7,402	0.01
(3) Options and agreements to purchase/sell	0	0.00	0	0.00
Total	*1,098,825	*0.85	16,162	0.01

* Include the holding of shares 697,681 on borrow products

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1.       DEALINGS (Note 4)

(a)      Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit USD (Note 5)
Purchase	33	225.232
Purchase	11	226.85
Purchase	8	226.38
Purchase	12	226.38
Purchase	100	228.95
Purchase	100	228.79
Purchase	100	228.92
Purchase	100	228.05
Purchase	10	227.79
Purchase	100	228.07
Purchase	100	227.07
Purchase	48	227.91
Purchase	100	227.75
Purchase	36	228.22
Purchase	52	227.91
Purchase	90	227.79
Purchase	2	228.3
Purchase	100	227.99
Purchase	52	227.99
Purchase	48	227.99
Purchase	100	226.02
Purchase	100	228.79
Purchase	100	227.9
Purchase	39	227.88
Purchase	8	226.24
Purchase	25	226.24
Purchase	7	226.24
Purchase	40	226.24
Purchase	20	226.24
Purchase	100	226.685
Purchase	98	227.67
Purchase	8	227.45
Purchase	92	227.45
Purchase	100	228.07
Purchase	100	227.5
Purchase	8	227.97
Purchase	92	227.97
Purchase	41	228.27
Purchase	59	228.27
Purchase	10	228.5
Purchase	100	228.03
Purchase	80	228.5
Purchase	10	228.5
Purchase	89	228.1
Purchase	9	228.1
Purchase	2	228.1
Purchase	5	228.16
Purchase	95	228.16
Purchase	100	228.16
Purchase	100	227.98
Purchase	100	228.45
Sale	100	227.42
Sale	100	227.38
Sale	23	226.65
Sale	10	226.65
Sale	10	226.65
Sale	10	225.99
Sale	24	226.42
Sale	11	226.96
Sale	11	226.94
Sale	1	226.43
Sale	55,900	226.38
Sale	8,226	226.38
Sale	3,800	226.38
Total Purchases	3,039
Total Sales	68,226

(b)      Derivatives transactions (other than options transactions)

Product name, e.g. CFD Nature of transaction (Note 6) Number of relevant securities (Note 7) Price per unit USD (Note 5)

(c)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name, e.g. call option Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii)      Exercising

Product name, e.g. call option Number of securities Exercise price per unit (Note 5)

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any 

relevant securities to which any derivative referred to on this form is referenced. 

If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            No

Date of disclosure	10/03/2021
Contact name	Société Générale - Disclosure team
Telephone number	+33 1 42 14 92 74
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEFIFLTVVIILIL